Date Filed | Type | Description |
05/25/2023 |
4
| Gottesdiener Keith Michael (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Granted 8,111 shares
@ $0 Granted 12,547 options to buy
@ $9.17, valued at
$115.1k
|
|
04/04/2023 |
4
| Gottesdiener Keith Michael (See Remarks) has filed a Form 4 on Prime Medicine, Inc.
Txns:
| Granted 497,738 options to buy
@ $12.3, valued at
$6.1M
|
|
10/19/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/01/2020 |
4
| Gottesdiener Keith Michael (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Granted 1,595 shares
@ $0 Granted 2,966 options to buy
@ $72.74, valued at
$215.7k
|
|
03/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/10/2020 |
4
| Gottesdiener Keith Michael (CEO & President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns:
| Exercised 33,072 options to buy
@ $4.59, valued at
$151.8k
|
|
07/17/2019 |
4
| Gottesdiener Keith Michael (CEO and President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns:
| Exercised 7,500 options to buy
@ $4.59, valued at
$34.4k
|
|
06/21/2019 |
4
| Gottesdiener Keith Michael (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Granted 1,570 shares
@ $0 Granted 2,174 options to buy
@ $82.25, valued at
$178.8k
|
|
03/19/2019 |
4
| Gottesdiener Keith Michael (CEO & President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns:
| Sold 7,961 shares
@ $30.04, valued at
$239.1k
Sold 2,329 shares
@ $30.27, valued at
$70.5k
|
|
03/15/2019 |
4
| Gottesdiener Keith Michael (CEO & President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns:
| Sold 7,782 shares
@ $30.06, valued at
$233.9k
Sold 1,506 shares
@ $30.05, valued at
$45.3k
|
|
02/28/2019 |
4
| Gottesdiener Keith Michael (CEO and President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns:
| Sold 635 shares
@ $30.13, valued at
$19.1k
Sold 1,814 shares
@ $30.01, valued at
$54.4k
|
|
02/20/2019 |
4
| Gottesdiener Keith Michael (CEO and President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns:
| Sold 12,002 shares
@ $30.02, valued at
$360.3k
Sold 918 shares
@ $30.05, valued at
$27.6k
|
|
02/15/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/24/2019 |
4
| Gottesdiener Keith Michael (CEO and President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns:
| Sold 15,674 shares
@ $30.05, valued at
$471k
Sold 105 shares
@ $30.21, valued at
$3.2k
|
|
01/22/2019 |
4
| Gottesdiener Keith Michael (CEO & President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns:
| Sold 10,115 shares
@ $30.01, valued at
$303.6k
|
|
01/17/2019 |
4
| Gottesdiener Keith Michael (CEO & President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns:
| Sold 662 shares
@ $30, valued at
$19.9k
|
|
12/06/2018 |
4
| Gottesdiener Keith Michael (CEO and President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns:
| Sold 563 shares
@ $30, valued at
$16.9k
|
|
11/06/2018 |
4
| Gottesdiener Keith Michael (CEO and President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns:
| Sold 16,500 shares
@ $30.08, valued at
$496.3k
|
|
06/22/2018 |
4
| Gottesdiener Keith Michael (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Granted 1,787 shares
@ $0 Granted 2,748 options to buy
@ $85.12, valued at
$233.9k
|
|
05/10/2018 |
4
| Gottesdiener Keith Michael (C.E.O. and President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns:
| Exercised 3,000 options to buy
@ $4.59, valued at
$13.8k
|
|
04/09/2018 |
4
| Gottesdiener Keith Michael (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS INC
Txns:
| Bought 1,171 shares
@ $64, valued at
$74.9k
|
|
02/16/2018 |
4
| Gottesdiener Keith Michael (CEO & President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns:
| Granted 175,000 options to buy
@ $25.79, valued at
$4.5M
|
|
10/10/2017 |
4
| Gottesdiener Keith Michael (CEO and President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns:
| Converted 27,262 shares
@ $0 Converted 27,262 convertible preferred
@ $0 |
|
10/04/2017 |
3
| Gottesdiener Keith Michael (CEO and President) has filed a Form 3 on RHYTHM PHARMACEUTICALS, INC. |
06/29/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
07/21/2016 |
4
| Gottesdiener Keith Michael (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS INC
Txns:
| Granted 2,407 shares
@ $0 Granted 3,196 options to buy
@ $145.22, valued at
$464.1k
|
|
07/21/2016 |
3
| Gottesdiener Keith Michael (Director) has filed a Form 3 on INTERCEPT PHARMACEUTICALS INC |